{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:53:44Z","timestamp":1783151624897,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-022-06106-1","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T10:05:22Z","timestamp":1645265122000},"page":"1583-1589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Flare of adult-onset Still\u2019s disease following mRNA COVID-19 vaccination: a case report and review of literature"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-0884","authenticated-orcid":false,"given":"Ji-Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-0795","authenticated-orcid":false,"given":"Ju-Yang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-393X","authenticated-orcid":false,"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-3367","authenticated-orcid":false,"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,19]]},"reference":[{"key":"6106_CR1","doi-asserted-by":"publisher","first-page":"118919","DOI":"10.1016\/j.lfs.2020.118919","volume":"267","author":"MM Silveira","year":"2021","unstructured":"Silveira MM, Moreira GMSG, Mendon\u00e7a M (2021) DNA vaccines against COVID-19: perspectives and challenges. Life Sci 267:118919","journal-title":"Life Sci"},{"key":"6106_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","volume":"19","author":"D van Riel","year":"2020","unstructured":"van Riel D, de Wit E (2020) Next-generation vaccine platforms for COVID-19. Nat Mater 19:810\u2013812","journal-title":"Nat Mater"},{"key":"6106_CR3","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/ijmm.2020.4640","volume":"46","author":"RN Kostoff","year":"2020","unstructured":"Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A (2020) [Comment] COVID-19 vaccine safety. Int J Mol Med 46:1599\u20131602","journal-title":"Int J Mol Med"},{"key":"6106_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14760584.2021.1875824","volume":"20","author":"S Soleimanpour","year":"2021","unstructured":"Soleimanpour S, Yaghoubi A (2021) COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 20:23\u201344","journal-title":"Expert Rev Vaccines"},{"key":"6106_CR5","doi-asserted-by":"publisher","first-page":"102506","DOI":"10.1016\/j.jaut.2020.102506","volume":"114","author":"Y Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez Y, Novelli L, Rojas M et al (2020) Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmunity 114:102506","journal-title":"J Autoimmunity"},{"key":"6106_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12026-014-8565-5","volume":"60","author":"C Selmi","year":"2014","unstructured":"Selmi C, Generali E, Massarotti M, Bianchi G, Scir\u00e9 CA (2014) New treatments for inflammatory rheumatic disease. Immunol Res 60:277\u2013288","journal-title":"Immunol Res"},{"key":"6106_CR7","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1136\/annrheumdis-2021-220541","volume":"80","author":"JW Bijlsma","year":"2021","unstructured":"Bijlsma JW (2021) EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs. Ann Rheum Dis 80:e156. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220541","journal-title":"Ann Rheum Dis"},{"key":"6106_CR8","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1002\/acr.24450","volume":"73","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Johnson SR, Anthony DD et al (2021) American College of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 2. Arthritis Rheumatol 73:e30\u2013e45","journal-title":"Arthritis Rheumatol"},{"key":"6106_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H et al (2021) Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 9:435. https:\/\/doi.org\/10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"issue":"Suppl 132","key":"6106_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.55563\/clinexprheumatol\/tvlpnc","volume":"39","author":"S Yamamoto","year":"2021","unstructured":"Yamamoto S, Nishimura K, Yo K, Waki D, Murabe H, Yokota T (2021) Flare-up of adult-onset Still\u2019s disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine. Clin Exp Rheumatol 39(Suppl 132):139\u2013140","journal-title":"Clin Exp Rheumatol"},{"key":"6106_CR11","doi-asserted-by":"publisher","unstructured":"Jeon YH, Lim DH, Choi SW, Choi SJ (2021) A flare of Still\u2019s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatol Int. 1-6. https:\/\/doi.org\/10.1007\/s00296-021-05052-6","DOI":"10.1007\/s00296-021-05052-6"},{"key":"6106_CR12","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","volume":"3","author":"F Leone","year":"2021","unstructured":"Leone F, Cerasuolo PG, Bosello SL et al (2021) Adult-onset Still\u2019s disease following COVID-19 vaccination. Lancet Rheumatol 3:e678\u2013e680","journal-title":"Lancet Rheumatol"},{"key":"6106_CR13","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2021-0035","author":"C Baicus","year":"2021","unstructured":"Baicus C, Delcea C, Pinte L, Dan GA (2021) Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still\u2019s disease. Does terminology matter? Rom J Intern Med. https:\/\/doi.org\/10.2478\/rjim-2021-0035","journal-title":"Rom J Intern Med"},{"key":"6106_CR14","doi-asserted-by":"publisher","first-page":"108878","DOI":"10.1016\/j.clim.2021.108878","volume":"233","author":"A Sharabi","year":"2021","unstructured":"Sharabi A, Shiber S, Molad Y (2021) Adult-onset Still\u2019s disease following mRNA COVID-19 vaccination. Clin Immunol 233:108878","journal-title":"Clin Immunol"},{"key":"6106_CR15","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","volume":"3","author":"D Magliulo","year":"2021","unstructured":"Magliulo D, Narayan S, Ue F, Boulougoura A, Badlissi F (2021) Adult-onset Still\u2019s disease after mRNA COVID-19 vaccine. Lancet Rheumatol 3:e680\u2013e682","journal-title":"Lancet Rheumatol"},{"key":"6106_CR16","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.3346\/jkms.2021.36.e344","volume":"36","author":"S-Y Park","year":"2021","unstructured":"Park S-Y, Lee K-H (2021) Adult-onset Still\u2019s disease after BNT162b2 mRNA COVID-19 vaccine. J Korean Med Sci 36:e344","journal-title":"J Korean Med Sci"},{"key":"6106_CR17","first-page":"196","volume":"23","author":"L Shechtman","year":"2021","unstructured":"Shechtman L, Lahad K, Ben-Zvi I (2021) Adult Still\u2019s disease triggered by influenza vaccine. Isr Med Assoc J 23:196\u2013197","journal-title":"Isr Med Assoc J"},{"key":"6106_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jbspin.2010.03.017","volume":"77","author":"WH Yoo","year":"2010","unstructured":"Yoo WH (2010) Adult onset Still\u2019s disease following influenza vaccination. Joint Bone Spine 77:373\u2013374","journal-title":"Joint Bone Spine"},{"key":"6106_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3109\/s10165-011-0418-7","volume":"21","author":"K Yoshioka","year":"2011","unstructured":"Yoshioka K, Fujimoto S, Oba H, Minami M, Aoki T (2011) Onset of adult-onset Still\u2019s disease following influenza vaccination. Mod Rheumatol 21:432\u2013435","journal-title":"Mod Rheumatol"},{"key":"6106_CR20","doi-asserted-by":"publisher","DOI":"10.12932\/AP-100121-1033","author":"K Jatuworapruk","year":"2021","unstructured":"Jatuworapruk K (2021) Adult-onset Still\u2019s disease preceded by influenza vaccination: coincidence or true association? Asian Pac J Allergy Immunol. https:\/\/doi.org\/10.12932\/AP-100121-1033","journal-title":"Asian Pac J Allergy Immunol"},{"key":"6106_CR21","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4102","author":"T Sato","year":"2021","unstructured":"Sato T, Takeo N, Matsuda-Hirose H, Abe K, Nishida H, Hatano Y (2021) Adult-onset Still\u2019s disease following pneumococcal vaccination. Eur J Dermatol. https:\/\/doi.org\/10.1684\/ejd.2021.4102","journal-title":"Eur J Dermatol"},{"key":"6106_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0248-8663(97)83425-X","volume":"19","author":"A Grasland","year":"1998","unstructured":"Grasland A, Le Ma\u00eetre F, Pouchot J, Hazera P, Bazin C, Vinceneux P (1998) Adult-onset Still\u2019s disease after hepatitis A and B vaccination? Rev Med Interne 19:134\u2013136","journal-title":"Rev Med Interne"},{"key":"6106_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P (2014) Adult-onset Still\u2019s disease. Autoimmun Rev 13:708\u2013722","journal-title":"Autoimmun Rev"},{"key":"6106_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","volume":"93","author":"R Giacomelli","year":"2018","unstructured":"Giacomelli R, Ruscitti P, Shoenfeld Y (2018) A comprehensive review on adult onset Still\u2019s disease. J Autoimmun 93:24\u201336","journal-title":"J Autoimmun"},{"key":"6106_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","volume":"13","author":"ATJ Maria","year":"2014","unstructured":"Maria ATJ, Le Quellec A, Jorgensen C, Touitou I, Rivi\u00e8re S, Guilpain P (2014) Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev 13:1149\u20131159","journal-title":"Autoimmun Rev"},{"key":"6106_CR26","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atag\u00fcnd\u00fcz P, Tabak F, Atag\u00fcnd\u00fcz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39:2085\u20132094","journal-title":"Clin Rheumatol"},{"key":"6106_CR27","doi-asserted-by":"publisher","first-page":"763313","DOI":"10.3389\/fimmu.2021.763313","volume":"12","author":"RK Roy","year":"2021","unstructured":"Roy RK, Sharma U, Wasson MK, Jain A, Hassan MI, Prakash H (2021) Macrophage activation syndrome and COVID 19: impact of MAPK driven immune-epigenetic programming by SARS-Cov-2. Front Immunol 12:763313","journal-title":"Front Immunol"},{"key":"6106_CR28","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","volume":"39","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 39:2055\u20132062","journal-title":"Clin Rheumatol"},{"key":"6106_CR29","doi-asserted-by":"publisher","unstructured":"Meng J, Ma Y, Jia J et al (2020) Cytokine storm in coronavirus disease 2019 and adult-onset Still\u2019s disease: similarities and differences. Front Immunol 11:603389. https:\/\/doi.org\/10.3389\/fimmu.2020.603389","DOI":"10.3389\/fimmu.2020.603389"},{"key":"6106_CR30","doi-asserted-by":"publisher","first-page":"102573","DOI":"10.1016\/j.autrev.2020.102573","volume":"19","author":"S Colafrancesco","year":"2020","unstructured":"Colafrancesco S, Alessandri C, Conti F, Priori R (2020) COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev 19:102573. https:\/\/doi.org\/10.1016\/j.autrev.2020.102573","journal-title":"Autoimmun Rev"},{"key":"6106_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/vaccines9050436","volume":"9","author":"AA Rabaan","year":"2021","unstructured":"Rabaan AA, Al-Ahmed SH, Muhammad J et al (2021) Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel) 9:436. https:\/\/doi.org\/10.3390\/vaccines9050436","journal-title":"Vaccines (Basel)"},{"key":"6106_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H (2020) Interleukin-6 in COVID-19: a systematic review and meta-analysis. Rev Med Virol 30:1\u20139","journal-title":"Rev Med Virol"},{"key":"6106_CR33","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1016\/S2665-9913(21)00072-2","volume":"3","author":"AD Bamidis","year":"2021","unstructured":"Bamidis AD, Koehler P, di Cristanziano V et al (2021) First manifestation of adult-onset Still\u2019s disease after COVID-19. Lancet Rheumatol 3:e319\u2013e321","journal-title":"Lancet Rheumatol"},{"key":"6106_CR34","doi-asserted-by":"publisher","first-page":"117954762199630","DOI":"10.1177\/1179547621996306","volume":"14","author":"A Alshablan","year":"2021","unstructured":"Alshablan A, Jabbad R, Tayeb S et al (2021) (2021) Diagnosis of adult onset Still\u2019s disease in a patient who has recovered from Coronavirus-19. Clin Med Insights Case Rep 14:1179547621996306","journal-title":"Clin Med Insights Case Rep"},{"key":"6106_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/1756-185X.14220","volume":"24","author":"C Baimukhamedov","year":"2021","unstructured":"Baimukhamedov C, Makhmudov S, Botabekova A (2021) Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection. Int J Rheum Dis 24:1440\u20131441","journal-title":"Int J Rheum Dis"},{"key":"6106_CR36","doi-asserted-by":"crossref","unstructured":"Park JK, Lee EB, Shin K et al. COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: clinical guidance of the Korean College of Rheumatology. J Korean Med Sci 36:e95.","DOI":"10.3346\/jkms.2021.36.e95"},{"key":"6106_CR37","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"Vojdani A, Kharrazian D (2020) Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217:108480","journal-title":"Clin Immunol"},{"key":"6106_CR38","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/ijbs.59233","volume":"17","author":"JW Park","year":"2021","unstructured":"Park JW, Lagniton PNP, Liu Y, Xu RH (2021) mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci 17:1446\u20131460","journal-title":"Int J Biol Sci"},{"key":"6106_CR39","doi-asserted-by":"publisher","first-page":"109504","DOI":"10.1016\/j.celrep.2021.109504","volume":"36","author":"C Bergamaschi","year":"2021","unstructured":"Bergamaschi C, Terpos E, Rosati M et al (2021) Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep 36:109504","journal-title":"Cell Rep"},{"key":"6106_CR40","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1073\/pnas.84.20.7251","volume":"84","author":"J Gauldie","year":"1987","unstructured":"Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon beta 2\/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A 84:7251\u20137255","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6106_CR41","unstructured":"Ritchie H, Mathieu E, Rod\u00e9s-Guirao L, et al (2020) Coronavirus pandemic (COVID-19). Published online at OurWorldData.org. https:\/\/ourworldindata.org\/covid-vaccinations. [Online Resource]"},{"key":"6106_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/jpm11121283","volume":"11","author":"L Pinte","year":"2021","unstructured":"Pinte L, Negoi F, Ionescu GD et al (2021) COVID-19 vaccine does not increase the risk of disease flare-ups among patients with autoimmune and immune-mediated diseases. J Pers Med 11:1283","journal-title":"J Pers Med"},{"key":"6106_CR43","doi-asserted-by":"publisher","first-page":"rkab043","DOI":"10.1093\/rap\/rkab043","volume":"5","author":"CJ Peet","year":"2021","unstructured":"Peet CJ, Papadopoulou C, Sombrito BRM, Wood MR, Lachmann HJ (2021) COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics. Rheumatol Adv Pract 5:rkab043. https:\/\/doi.org\/10.1093\/rap\/rkab043","journal-title":"Rheumatol Adv Pract"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06106-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:07:17Z","timestamp":1651316837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06106-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,19]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6106"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06106-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,19]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The informed consent has been obtained from the patient. The protocol was waived because of retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was provided by the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was provided by the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}